Delayed Graft Function Recruiting Phase 0 Trials for Everolimus (DB01590)

Also known as: Graft Function, Delayed

IndicationStatusPhase
DBCOND0004880 (Delayed Graft Function)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02134288Belatacept for Renal Transplant Recipients With Delayed Graft FunctionTreatment